SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-020158
Filing Date
2024-02-26
Accepted
2024-02-26 16:10:56
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fate-20231231.htm   iXBRL 10-K 2886502
2 EX-10.41 fate-ex10_41.htm EX-10.41 31229
3 EX-10.42 fate-ex10_42.htm EX-10.42 228698
4 EX-14.1 fate-ex14_1.htm EX-14.1 71042
5 EX-23.1 fate-ex23_1.htm EX-23.1 5504
6 EX-31.1 fate-ex31_1.htm EX-31.1 11680
7 EX-31.2 fate-ex31_2.htm EX-31.2 12574
8 EX-32.1 fate-ex32_1.htm EX-32.1 7123
9 EX-32.2 fate-ex32_2.htm EX-32.2 7345
10 EX-97.1 fate-ex97_1.htm EX-97.1 59086
11 GRAPHIC img142887423_0.jpg GRAPHIC 45656
12 GRAPHIC img142887423_1.jpg GRAPHIC 18824
13 GRAPHIC img142887423_2.jpg GRAPHIC 61521
  Complete submission text file 0000950170-24-020158.txt   11936677

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fate-20231231.xsd EX-101.SCH 1656143
89 EXTRACTED XBRL INSTANCE DOCUMENT fate-20231231_htm.xml XML 1924387
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36076 | Film No.: 24678816
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)